Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 513.56% is 27% below its 1-year average of 705.48%, near the low end of its 1-year range (513.56%–873.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 27.20% below its 12-month average of 705.48%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 513.56%.
RETURN ON EQUITY (ROE)
513.56%
RETURN ON EQUITY (ROE) AVG TTM
705.48%
RETURN ON EQUITY (ROE) AVG 3Y
705.48%
RETURN ON EQUITY (ROE) AVG 5Y
705.48%
RETURN ON EQUITY (ROE) AVG 10Y
705.48%
RETURN ON EQUITY (ROE) AVG 15Y
4.59%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-27.20%
CURRENT VS 3Y AVG
-27.20%
CURRENT VS 5Y AVG
-27.20%
CURRENT VS 10Y AVG
-27.20%
CURRENT VS 15Y AVG
+11088.36%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+1322.48%
vs the sector median at left
SANUWAVE Health Inc.
Market Cap
$44.84M
Return on Equity (ROE)
513.56%
TTM Avg
705.48%
3Y Avg
705.48%
5Y Avg
705.48%
Market Cap
$45.08M
Return on Equity (ROE)
-212.45%
TTM Avg
-170.64%
3Y Avg
-104.70%
5Y Avg
-78.05%
Market Cap
$46.31M
Return on Equity (ROE)
N/A
TTM Avg
-206.96%
3Y Avg
-221.50%
5Y Avg
-349.91%
Market Cap
$44.27M
Return on Equity (ROE)
123.04%
TTM Avg
-60.38%
3Y Avg
-75.18%
5Y Avg
-82.51%
Market Cap
$43.85M
Return on Equity (ROE)
-260.45%
TTM Avg
-109.97%
3Y Avg
-78.03%
5Y Avg
-56.14%
Market Cap
$43.70M
Return on Equity (ROE)
-288.49%
TTM Avg
-102.07%
3Y Avg
-71.41%
5Y Avg
-78.05%
Market Cap
$43.65M
Return on Equity (ROE)
-102.45%
TTM Avg
30.59%
3Y Avg
217.16%
5Y Avg
155.68%
Market Cap
$46.73M
Return on Equity (ROE)
-28.20%
TTM Avg
-53.22%
3Y Avg
-59.23%
5Y Avg
-46.35%
Market Cap
$47.64M
Return on Equity (ROE)
-170.94%
TTM Avg
-132.56%
3Y Avg
-85.15%
5Y Avg
-88.00%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SANUWAVE Health Inc. (SNWV) | $44.84M | 513.56% | 705.48% | 705.48% | 705.48% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.08M | -212.45% | -170.64% | -104.70% | -78.05% |
| Celularity Inc. (CELU)vs › | $46.31M | N/A | -206.96% | -221.50% | -349.91% |
| DarioHealth Corp. (DRIO)vs › | $44.27M | 123.04% | -60.38% | -75.18% | -82.51% |
| CVRx, Inc. (CVRX)vs › | $43.85M | -260.45% | -109.97% | -78.03% | -56.14% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.70M | -288.49% | -102.07% | -71.41% | -78.05% |
| BioStem Technologies, Inc. (BSEM)vs › | $43.65M | -102.45% | 30.59% | 217.16% | 155.68% |
| Instil Bio, Inc. (TIL)vs › | $46.73M | -28.20% | -53.22% | -59.23% | -46.35% |
| Lite Strategy, Inc. (LITS)vs › | $47.64M | -170.94% | -132.56% | -85.15% | -88.00% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.93M | -161.19% | -40.99% | -40.41% | -33.61% |
ROE
513.6%
ROA
39.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 513.56% |
| 2026-03-31 | 873.23% |
| 2025-12-31 | 729.65% |
| 2014-06-30 | -894.42% |
| 2014-03-31 | -496.22% |
| 2011-06-30 | -698.26% |
